Isomorphic Labs' funding war chest swells by another $5B firstwordpharma.com/story/8445112
Latest posts 5
SELLAS rockets after off-the-shelf cancer vaccine shows AML survival gain $SLS firstwordpharma.com/story/8444365
AriBio sees subgroup hope for AR1001 in pivotal study for early Alzheimer's firstwordpharma.com/story/8444156
With $173M in hand, Marrow hopes to capitalise on promise of genetic medicine for blood disorders firstwordpharma.com/story/8444075
Roche wins FDA nod for oral SERD in ESR1-mutated breast cancer $RHHBY firstwordpharma.com/story/8443512